Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss of $0.42

Rapport Therapeutics, Inc. (NASDAQ: RAPP) reported Q1 EPS of ($0.42). Revenue for the quarter came in at $20 million.

For earnings history and earnings-related data on Rapport Therapeutics, Inc. (RAPP) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• GMR Solutions to reprice $2.9B term loan, pay down $200M in debt